A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: RhEDI-8t

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 5, 2012, Pages 731-739

  Zhang, Ling ^a,b   Shen, Xi ^a   Lu, Qing ^a   Zhou, Qingwei ^c   Gu, Jiaqi ^a   Gan, Renbao ^c   Zhang, Hui ^c   Sun, Xiaodong ^b   Xie, Bing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Shanghai Apeloa Pharmaceutical Research Institute   (China)

Author keywords

Neovascularization . Vascular endothelial growth factor . Age related macular degeneration

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN; FIBROBLAST GROWTH FACTOR; INHIBITOR PROTEIN; RECOMBINANT ENDOTHELIAL GROWTH INHIBITOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OCULAR BLOOD VESSEL; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; SUBRETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CHOROIDAL NEOVASCULARIZATION; COLLAGEN TYPE VIII; DISEASE MODELS, ANIMAL; ENDOSTATINS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INTRAVITREAL INJECTIONS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; RETINAL NEOVASCULARIZATION; SPECIFIC PATHOGEN-FREE ORGANISMS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862877172     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1765-y     Document Type: Article

References (33)

1. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285 (21): 1182-1186
2. Hosseini H, Nejabat M (2007) A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents. Med Hypotheses 68 (4): 799-801
3. Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA (1998) Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39 (1): 180-188
4. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (2): 277-285
5. Abdollahi A, Hahnfeldt P, Maercker C, Gröne HJ, Debus J, Ansorge W, Folkman J, Hlatky L, Huber PE (2004) Endostatin's antiangiogenic signaling network. Mol Cell 13 (5): 649-663
6. Ramchandran R, Dhanabal M, Volk R, Waterman MJ, Segal M, Lu H, Knebelmann B, Sukhatme VP (1999) Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 255 (3): 735-739
7. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW, Weichselbaum RR, Sukhatme VP, Kalluri R (2000) Antiangiogenic cues from vascular basement membrane collagen. Cancer Res 60 (9): 2520-2526
8. Xu R, Yao ZY, Xin L, Zhang Q, Li TP, Gan RB (2001) NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis. Biochem Biophys Res Commun 289 (1): 264-268
9. Risau W (1997) Mechanisms of angiogenesis. Nature 386: 671-674
10. Shono T, Kanetake H, Kanda S (2001) The role of mitogen activated protein kinase activation within focal adhesions in chemotaxis toward FGF-2 by murine brain capillary endothelial cells. Exp Cell Res 264: 275-283
11. Kiec-Wilk B, Grzybowska-Galuszka J, Polus A, Pryjma J, Knapp A, Kristiansen K (2010) The MAPK-dependent regulation of the Jagged/notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC. J Physiol Pharmacol 61 (2): 217-225
12. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 151 (1): 281-291
13. Mendrinos E, Petropoulos IK, Mangioris G, Papadopoulou DN, Stangos AN, Pournaras CJ (2008) Lactate-induced retinal arteriolar vasodilation implicates neuronal nitric oxide synthesis in minipigs. Invest Ophthalmol Vis Sci 49 (11): 5060-5066
14. Tobe T, Ortega S, Luna JD, Derevjanik NL, Vinores SA, Zack DJ, Vinores SA, Basilico C, Campochiaro PA (1998) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153 (5): 1641-1646
15. Das A, McGuire PG (2003) Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Progr Retin Eye Res 22 (6): 721-748
16. Campochiaro PA, Hackett SF (2003) Ocular neovascularization: a valuable model system. Oncogene 22 (42): 6537-6548
17. Mori K, Ando A, Gehlbach P, Nesbitt D, Takahashi K, Goldsteen D, Penn M, Chen CT, Mori K, Melia M, Phipps S, Moffat D, Brazzell K, Liau G, Dixon KH, Campochiaro PA (2001) Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am J Pathol 159 (1): 313-320
18. Noma H, Funatsu H, Yamashita H, Kitano S, Mishima HK, Hori S (2002) Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin. Arch Ophthalmol 120 (8): 1075-1080
19. Bhutto IA, Kim SY, McLeod DS, Merges C, Fukai N, Olsen BR, Lutty GA (2004) Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci 45 (5): 1544-1552
20. Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaissé J (2000) Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486 (3): 247-251
21. Lee SJ, Jang JW, Kim YM, Lee HI, Jeon JY, Kwon YG, Lee ST (2002) Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett 519 (1-3): 147-152
22. Nyberg P, Xie L, Kalluri R (2005) Endogenous inhibitors of angiogenesis. Cancer Res 65: 3967-3979
23. Zatterstrom UK, Felbor U, Fukai N, Olsen BR (2000) Collagen XVIII/endostatin structure and functional role in angiogenesis. Cell Struct Funct 25: 97-101
24. Ni Q, Ji H, Zhao Z, Fan X, Xu C (2009) Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-relatedmechanism. Eur J Pharmacol 614 (1-3): 1-6
25. Bai RZ,Wu Y, Liu Q, Xie K,Wei YQ,Wang YS, Liu K, Luo Y, Su JM, Hu B, Liu JY, Li Q, Niu T, Zhao ZW, Yang L (2009) Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin. J Exp Clin Cancer Res 5: 28-31
26. Ouyang XS, Wang X, Ling MT, Wong HL, Tsao SW, Wong YC (2002) Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16 (INK4a)/pRB pathway. Carcinogenesis 23 (5): 721-725
27. Ling MT, Wang X, Ouyang XS, Lee TK, Fan TY, Xu K, Tsao SW, Wong YC (2002) Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth. Oncogene 21 (55): 8498-8505
28. Seo MS, Kwak N, Ozaki H, Yamada H, Okamoto N, Yamada E, Fabbro D, Hofmann F, Wood JM, Campochiaro PA (1999) Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol 154 (6): 1743-1753
29. Lu F, Adelman RA (2009) Are intravitreal bevacizumab and ranibizumab effective in a rat model of choroidal neovascularization? Graefes Arch Clin Exp Ophthalmol 247 (2): 171-177
30. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79 (2): 315-328
31. O'Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J (1999) Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 285 (5435): 1926-1928
32. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247 (4938): 77-79
33. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285 (5425): 245-248